Toxic Epidermal Necrolysis: A Clinical Case Report with Emphasis on Diagnosis, Management, and Prognostic Implications

Main Article Content

Samantha Castro Cortés
Karla Itzel Sánchez Gutiérrez
Renata Fernanda Rodríguez Castro

Abstract

Toxic epidermal necrolysis (TEN) is a rare, life-threatening dermatologic emergency characterized by extensive keratinocyte apoptosis, resulting in widespread epidermal detachment and mucosal involvement. Its pathogenesis is primarily linked to an immune-mediated response triggered by certain medications. This report presents a case of a 45-year-old female who developed TEN following administration of an antibiotic regimen. The patient exhibited progressive skin detachment affecting over 30% of the body surface area, with concurrent ocular and oral mucosal involvement. Despite initial delays in diagnosis, aggressive management with fluid resuscitation, prompt drug discontinuation, and systemic immunosuppressants led to stabilization and eventual recovery. This case highlights the importance of early recognition, the need for a multidisciplinary approach, and the challenges in managing complications such as secondary infections and multi-organ dysfunction. Additionally, we discuss the diagnostic criteria, therapeutic options, and the role of emerging therapies, providing a comprehensive overview for clinicians facing similar cases.

Article Details

How to Cite
Samantha Castro Cortés, Karla Itzel Sánchez Gutiérrez, & Renata Fernanda Rodríguez Castro. (2024). Toxic Epidermal Necrolysis: A Clinical Case Report with Emphasis on Diagnosis, Management, and Prognostic Implications. International Journal of Medical Science and Clinical Research Studies, 4(10), 1785–1787. https://doi.org/10.47191/ijmscrs/v4-i10-10
Section
Articles

References

I. Guerrero-Martinez, M et al. Toxic epidermal necrolysis: Dermatol-Rev Mex Torres-Navarro I, 2023; 67 (4): 501-517.

II. Torres-Navarro I, Briz-Redón Á, Botella-Estrada R. Systemic therapies for Stevens-Johnson syndrome and toxic epider- mal necrolysis: a SCORTEN-based systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2021; 35 (1): 159-171. doi: 10.1111/jdv.16685.

III. Alfonso- Estrella, A. et al. Toxic epidermal necrolysis: a critical illness paradigm. Rev Bras Ter Intensiva. 2017;29(4):499-508

IV. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC. Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 1995; 131: 539-543.

V. oujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990; 23: 1039-1058.6. Becker DS. Toxic epidermal necrolysis. Lancet 1998; 351: 1417-1420.

VI. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 1994; 102: S28-S33.

VII. Tay YK, Huff JC, Weston WL. Mycoplasma pneumoniae infection is associated with Stevens-Johnson syndrome, not erythema multiforme (Von Hebra). J Am Acad Dermatol 1996; 35: 757-760.

VIII. Brufau Redondo C. Eritema polimorfo. Piel 1991; 6: 321-329.